Home / Current Issue / Paper 1715278
Theranostic Science Development with NMR/MRI/Radioligand Study; A Call for Collaborative Research in Target Delivery
Subject area: Biological & Medical Sciences · Area of research: Radiopharmacy and NMR Spectroscopy
DOI: https://doi.org/10.64388/IREV9I9-1715278
Abstract
There has been a wide spread in the cases of cancer in the recent decades with different types of cancers emerging every decade (Yang et al, 2018), management has evolved from great study with the discovery of chemotherapeutic agents. However, the adverse effects from these chemotherapeutic agents and chemotherapy (irradiation) have pointed the needs for more targeted drug discovery. In the last decades, development of targeted drug delivery via monoclonal antibodies and others has helped sharpen the management of cancer.
How to cite this paper
Taiwo Temitope Philip "Theranostic Science Development with NMR/MRI/Radioligand Study; A Call for Collaborative Research in Target Delivery" Iconic Research And Engineering Journals Volume 9 Issue 9 2026 Page 3546-3548 https://doi.org/10.64388/IREV9I9-1715278
Taiwo Temitope Philip "Theranostic Science Development with NMR/MRI/Radioligand Study; A Call for Collaborative Research in Target Delivery" Iconic Research And Engineering Journals, vol. 9, no. 9, Mar. 2026, doi: https://doi.org/10.64388/IREV9I9-1715278
Taiwo Temitope Philip (2026). Theranostic Science Development with NMR/MRI/Radioligand Study; A Call for Collaborative Research in Target Delivery. Iconic Research And Engineering Journals, 9(9). doi: https://doi.org/10.64388/IREV9I9-1715278
Taiwo Temitope Philip "Theranostic Science Development with NMR/MRI/Radioligand Study; A Call for Collaborative Research in Target Delivery" Iconic Research And Engineering Journals, vol. 9, no. 9, Mar. 2026. Crossref, https://doi.org/10.64388/IREV9I9-1715278
@article{1715278,
author = {Taiwo Temitope Philip},
title = {Theranostic Science Development with NMR/MRI/Radioligand Study; A Call for Collaborative Research in Target Delivery},
journal = {Iconic Research And Engineering Journals},
year = {2026},
volume = {9},
number = {9},
pages = {3546-3548},
issn = {2456-8880},
url = {https://www.irejournals.com/formatedpaper/1715278.pdf},
abstract = {There has been a wide spread in the cases of cancer in the recent decades with different types of cancers emerging every decade (Yang et al, 2018), management has evolved from great study with the discovery of chemotherapeutic agents. However, the adverse effects from these chemotherapeutic agents and chemotherapy (irradiation) have pointed the needs for more targeted drug discovery. In the last decades, development of targeted drug delivery via monoclonal antibodies and others has helped sharpen the management of cancer.},
month = {March},
doi = {https://doi.org/10.64388/IREV9I9-1715278}
}